» Articles » PMID: 20493775

Roles of Small RNAs in Tumor Formation

Overview
Journal Trends Mol Med
Date 2010 May 25
PMID 20493775
Citations 133
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs (miRNAs) are small noncoding RNAs that act as post-transcriptional repressors of gene expression in organisms ranging from plants to humans. A widespread role for miRNAs in diverse molecular processes driving the initiation and progression of various tumor types has recently been described. Here, we discuss the etiology of the aberrant expression of miRNAs in human cancers and their role in tumor metastasis, which might define miRNAs as oncogenes or tumor suppressors. Moreover, we highlight the genomic/epigenetic alterations and transcriptional/post-transcriptional mechanisms associated with the misexpression of miRNAs in cancer. A better understanding of miRNA biology might ultimately yield further insight into the molecular mechanisms of tumorigenesis and new therapeutic strategies against cancer.

Citing Articles

Identification of novel microRNAs: Biomarkers for pathogenesis of hepatocellular carcinoma in mice model.

Priya S, Kma L Biochem Biophys Rep. 2025; 41:101896.

PMID: 39881957 PMC: 11774814. DOI: 10.1016/j.bbrep.2024.101896.


The role of epigenetics in women's reproductive health: the impact of environmental factors.

Yu X, Xu J, Song B, Zhu R, Liu J, Liu Y Front Endocrinol (Lausanne). 2024; 15:1399757.

PMID: 39345884 PMC: 11427273. DOI: 10.3389/fendo.2024.1399757.


Fluorescent DNA tetrahedral probe with catalytic hairpin self-assembly reaction for imaging of miR-21 and miR-155 in living cells.

Wang S, Guang J, Gao Y, Fan B, Liang Y, Pan J Mikrochim Acta. 2024; 191(8):462.

PMID: 38990374 DOI: 10.1007/s00604-024-06529-4.


Relapse and Survival in Bladder Cancer Patients Undergoing microRNA-129 and microRNA-145 Assays.

ELfieky M, Abd El Rahman M, Fayed A, Al-Qaim Z, Aldhalmi A, Badr E Asian Pac J Cancer Prev. 2024; 25(6):2113-2121.

PMID: 38918674 PMC: 11382840. DOI: 10.31557/APJCP.2024.25.6.2113.


Liquid biopsy utilizing miRNA in patients with advanced breast cancer treated with cyclin‑dependent kinase 4/6 inhibitors.

Kubeczko M, Tudrej P, Tyszkiewicz T, Krzywon A, Oczko-Wojciechowska M, Jarzab M Oncol Lett. 2024; 27(4):181.

PMID: 38464342 PMC: 10921259. DOI: 10.3892/ol.2024.14314.


References
1.
Mayr C, Hemann M, Bartel D . Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science. 2007; 315(5818):1576-9. PMC: 2556962. DOI: 10.1126/science.1137999. View

2.
Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M . Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell. 2006; 9(3):189-98. DOI: 10.1016/j.ccr.2006.01.025. View

3.
Lu L, Katsaros D, de la Longrais I, Sochirca O, Yu H . Hypermethylation of let-7a-3 in epithelial ovarian cancer is associated with low insulin-like growth factor-II expression and favorable prognosis. Cancer Res. 2007; 67(21):10117-22. DOI: 10.1158/0008-5472.CAN-07-2544. View

4.
Costinean S, Zanesi N, Pekarsky Y, Tili E, Volinia S, Heerema N . Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. Proc Natl Acad Sci U S A. 2006; 103(18):7024-9. PMC: 1459012. DOI: 10.1073/pnas.0602266103. View

5.
DeYoung M, Horak P, Sofer A, Sgroi D, Ellisen L . Hypoxia regulates TSC1/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling. Genes Dev. 2008; 22(2):239-51. PMC: 2192757. DOI: 10.1101/gad.1617608. View